Anti-angiogenic therapy in advanced non-small cell lung carcinoma (NSCLC): is there a role in subsequent lines of therapy?

被引：3
作者：
Al Farsi, Abdulaziz [1 ]
Ellis, Peter M. [1 ]
机构：
[1] Juravinski Canc Ctr, Dept Med Oncol, Hamilton, ON L8V 5C2, Canada
来源：
JOURNAL OF THORACIC DISEASE | 2015年 / 7卷 / 03期
关键词：
PHASE-III TRIAL; DOUBLE-BLIND; GROWTH-FACTOR; PLUS ERLOTINIB; CANCER; PLACEBO; BEVACIZUMAB; CHEMOTHERAPY; CARBOPLATIN; VANDETANIB;
D O I：
10.3978/j.issn.2072-1439.2015.01.41
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：214 / 216
页数：3
相关论文
共 20 条
  • [1] Biology of platelet-derived growth factor and its involvement in disease
    Alvarez, Ricardo H.
    Kantarjian, Hagop M.
    Cortes, Jorge E.
    [J]. MAYO CLINIC PROCEEDINGS, 2006, 81 (09) : 1241 - 1257
  • [2] Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: Relation to prognosis
    Bonnesen, Barbara
    Pappot, Helle
    Holmstav, Julie
    Skov, Birgit Guldhammer
    [J]. LUNG CANCER, 2009, 66 (03) : 314 - 318
  • [3] American Society of Clinical Oncology Perspective: Raising the Bar for Clinical Trials by Defining Clinically Meaningful Outcomes
    Ellis, Lee M.
    Bernstein, David S.
    Voest, Emile E.
    Berlin, Jordan D.
    Sargent, Daniel
    Cortazar, Patricia
    Garrett-Mayer, Elizabeth
    Herbst, Roy S.
    Lilenbaum, Rogerio C.
    Sima, Camelia
    Venook, Alan P.
    Gonen, Mithat
    Schilsky, Richard L.
    Meropol, Neal J.
    Schnipper, Lowell E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (12) : 1277 - +
  • [4] Multitargeted anti-angiogenic agents and NSCLC: Clinical update and future directions
    Ellis, Peter M.
    Al-Saleh, Khalid
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 84 (01) : 47 - 58
  • [5] A Systematic Review and Canadian Consensus Recommendations on the Use of Biomarkers in the Treatment of Non-small Cell Lung Cancer
    Ellis, Peter M.
    Blais, Normand
    Soulieres, Dennis
    Ionescu, Diana N.
    Kashyap, Meenakshi
    Liu, Geoff
    Melosky, Barb
    Reiman, Tony
    Romeo, Phillippe
    Shepherd, Frances A.
    Tsao, Ming-Sound
    Leighl, Natasha B.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (08) : 1379 - 1391
  • [6] Hanna NH, 2013, J CLIN ONCOL, V31
  • [7] Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial
    Herbst, Roy S.
    Ansari, Rafat
    Bustin, Frederique
    Flynn, Patrick
    Hart, Lowell
    Otterson, Gregory A.
    Vlahovic, Gordana
    Soh, Chang-Heok
    O'Connor, Paula
    Hainsworth, John
    [J]. LANCET, 2011, 377 (9780) : 1846 - 1854
  • [8] Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial
    Herbst, Roy S.
    Sun, Yon
    Eberhardt, Wilfried E. E.
    Germonpre, Paul
    Saijo, Nagahiro
    Zhou, Caicun
    Wang, Jie
    Li, Longyun
    Kabbinavar, Fairooz
    Ichinose, Yukito
    Qin, Shukui
    Zhang, Li
    Biesma, Bonne
    Heymach, John V.
    Langmuir, Peter
    Kennedy, Sarah J.
    Tada, Hiroomi
    Johnson, Bruce E.
    [J]. LANCET ONCOLOGY, 2010, 11 (07) : 619 - 626
  • [9] TRIBUTE: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer
    Herbst, RS
    Prager, D
    Hermann, R
    Fehrenbacher, L
    Johnson, BE
    Sandler, A
    Kris, MG
    Tran, HT
    Klein, P
    Li, X
    Ramies, D
    Johnson, DH
    Miller, VA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 5892 - 5899
  • [10] BIBF 1120: Triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy
    Hilberg, Frank
    Roth, Gerald J.
    Krssak, Martin
    Kautschitsch, Susanna
    Sommergruber, Wolfgang
    Tontsch-Grunt, Ulrike
    Garin-Chesa, Pilar
    Bader, Gerd
    Zoephel, Andreas
    Quant, Jens
    Heckel, Armin
    Rettig, Wolfgang J.
    [J]. CANCER RESEARCH, 2008, 68 (12) : 4774 - 4782
12